1. |
Kivela T. The epidemiological challenge of the most frequent eye cancer: retinoblastoma, an issue of birth and death[J]. Br J Ophthalmol, 2009, 93(9): 1129-1131. DOI: 10.1136/bjo.2008.150292.
|
2. |
Shields CL, Shields JA. Basic understanding of current classification and management of retinoblastoma[J]. Curr Opin Ophthalmol, 2006, 17(3): 228-234. DOI: 10.1097/01.icu.0000193079.55240.18.
|
3. |
Gao J, Zeng J, Guo B, et al. Clinical presentation and treatment outcome of retinoblastoma in children of South Western China[J/OL]. Medicine (Baltimore), 2016, 95(42): e5204[2016-10-01]. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5079341/. DOI: 10.1097/MD.0000000000005204.
|
4. |
Gao YJ, Qian J, Yue H, et al. Clinical characteristics and treatment outcome of children with intraocular retinoblastoma: a report from a Chinese cooperative group[J]. Pediatr Blood Cancer, 2011, 57(7): 1113-1116. DOI: 10.1002/pbc.23002.
|
5. |
Jain M, Rojanaporn D, Chawla B, et al. Retinoblastoma in Asia[J]. Eye (Lond), 2019, 33(1): 87-96. DOI: 10.1038/s41433-018-0244-7.
|
6. |
Shields CL, Mashayekhi A, Au AK, et al. The International Classification of Retinoblastoma predicts chemoreduction success[J]. Ophthalmology, 2006, 113(12): 2276-2280. DOI: 10.1016/j.ophtha.
|
7. |
钱江, 薛康. 晚期视网膜母细胞瘤可否保眼治疗[J]. 中华眼科杂志, 2016, 52(10): 728-732. DOI: 10.3760/cma.j.issn.0412-4081.2016.10.003.Qian J, Xue K. Eyeball salvage treatment or enucleation for advanced retinoblastoma[J]. Chin J Ophthalmol, 2016, 52(10): 728-732. DOI: 10.3760/cma.j.issn.0412-4081.2016.10.003.
|
8. |
Chawla B, Jain A, Azad R. Conservative treatment modalities in retinoblastoma[J]. Indian J Ophthalmol, 2013, 61(9): 479-485. DOI: 10.4103/0301-4738.119424.
|
9. |
Abramson DH. Retinoblastoma in the 20th century: past success and future challenges the Weisenfeld lecture[J]. Invest Ophthalmol Vis Sci, 2005, 46(8): 2683-2691. DOI: 10.1167/iovs.04-1462.
|
10. |
Skalet AH, Gombos DS, Gallie BL, et al. Screening children at risk for retinoblastoma: consensus report from the American Association of Ophthalmic Oncologists and Pathologists[J]. Ophthalmology, 2018, 125(3): 453-458. DOI: 10.1016/j.ophtha.2017.09.001.
|
11. |
Rothschild PR, Levy D, Savignoni A, et al. Familial retinoblastoma: fundus screening schedule impact and guideline proposal. A retrospective study[J]. Eye (Lond), 2011, 25(12): 1555-1561. DOI: 10.1038/eye.2011.198.
|
12. |
Xu K, Rosenwaks Z, Beaverson K, et al. Preimplantation genetic diagnosis for retinoblastoma: the first reported liveborn[J]. Am J Ophthalmol, 2004, 137(1): 18-23. DOI: 10.1016/s0002-9394(03)00872-9.
|
13. |
Stathopoulos C, Say EAT, Shields CL. Prenatal ultrasonographic detection and prenatal (prior to birth) management of hereditary retinoblastoma[J]. Graefe's Arch Clin Exp Ophthalmol, 2018, 256(4): 861-862. DOI: 10.1007/s00417-017-3841-4.
|
14. |
Staffieri SE, McGillivray G, Elder JE, et al. Managing fetuses at high risk of retinoblastoma: lesion detection on screening MRI[J]. Prenat Diagn, 2015, 35(2): 174-178. DOI: 10.1002/pd.4514.
|
15. |
中华医学会眼科学分会眼底病学组, 中华医学会儿科学分会眼科学组, 中华医学会眼科学分会眼整形眼眶病学组. 中国视网膜母细胞瘤诊断和治疗指南(2019年)[J]. 中华眼科杂志, 2019, 55(10): 726-738. DOI: 10.3760/cma.j.issn.0412-4081.2019.10.003.Ocular Fundus Group of Ophthalmology Society of Chinese Medical Association, Ophthalmology Group of Pediatrics Branch of Chinese Medical Association, Ophthalmology and Orbital Surgery Group of Ophthalmology Society of Chinese Medical Association. Chinese guidelines for diagnosis and treatment of retinoblastoma[J]. Chin J Ophthalmol, 2019, 55(10): 726-738. DOI: 10.3760/cma.j.issn.0412-4081.2019.10.003.
|
16. |
项道满, 贺平. 关于新生儿眼底筛查的专家共识[J]. 中国斜视与小儿眼科杂志, 2018, 26(3): 1-3. DOI: 10.3969/J.ISSN.1005-328X.2018.03.001.Xiang DM, He P. Expert consensus on neonatal fundus screening[J]. Chinese Journal of Strabismus & Pediatric Ophthalmology, 2018, 26(3): 1-3. DOI: 10.3969/J.ISSN.1005-328X.2018.03.001.
|
17. |
Shields CL, Shields JA. New strategies in the treatment of unilateral sporadic retinoblastoma[J]. J Pediatr Ophthalmol Strabismus, 2015, 52(3): 134-137. DOI: 10.3928/01913913-20150427-01.
|
18. |
Shields CL, Meadows AT, Shields JA, et al. Chemoreduction for retinoblastoma may prevent intracranial neuroblastic malignancy (trilateral retinoblastoma)[J]. Arch Ophthalmol, 2001, 119(9): 1269-1272. DOI: 10.1001/archopht.119.9.1269.
|
19. |
Shields CL, Shelil A, Cater J, et al. Development of new retinoblastomas after 6 cycles of chemoreduction for retinoblastoma in 162 eyes of 106 consecutive patients[J]. Arch Ophthalmol, 2003, 121(11): 1571-1576. DOI: 10.1001/archopht.121.11.1571.
|
20. |
Kaliki S, Gupta Rathi S, Patel A. Routine fundus screening of families of children with retinoblastoma: a prospective study of 131 consecutive families[J]. Retina, 2019, 39(7): 1326-1332. DOI: 10.1097/IAE.0000000000002134.
|
21. |
Greger V, Passarge E, Hopping W, et al. Epigenetic changes may contribute to the formation and spontaneous regression of retinoblastoma[J]. Hum Genet, 1989, 83(2): 155-158. DOI: 10.1007/BF00286709.
|